Title:
ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/020846
Kind Code:
A1
Abstract:
Provided are an anti-4-1BB/anti-HER2 bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.
Inventors:
CHUNG HYEJIN (KR)
YONG YERYOUNG (KR)
PARK KYEONGSU (KR)
PARK EUNYOUNG (KR)
JUNG UI-JUNG (KR)
LEE YANGSOON (KR)
KIM EUNJUNG (KR)
SON YONG-GYU (KR)
SON WONJUN (KR)
AHN SEAWON (KR)
YEOM DONGHOON (KR)
LEE CHANMOO (KR)
HONG JUNGHYEON (KR)
SONG MOO YOUNG (KR)
LEE EUN-JUNG (KR)
LEE NA RAE (KR)
PARK YOUNG BONG (KR)
LEE EUN-JUNG (KR)
KIM TAEWANG (KR)
YONG YERYOUNG (KR)
PARK KYEONGSU (KR)
PARK EUNYOUNG (KR)
JUNG UI-JUNG (KR)
LEE YANGSOON (KR)
KIM EUNJUNG (KR)
SON YONG-GYU (KR)
SON WONJUN (KR)
AHN SEAWON (KR)
YEOM DONGHOON (KR)
LEE CHANMOO (KR)
HONG JUNGHYEON (KR)
SONG MOO YOUNG (KR)
LEE EUN-JUNG (KR)
LEE NA RAE (KR)
PARK YOUNG BONG (KR)
LEE EUN-JUNG (KR)
KIM TAEWANG (KR)
Application Number:
PCT/KR2020/009871
Publication Date:
February 04, 2021
Filing Date:
July 27, 2020
Export Citation:
Assignee:
ABL BIO INC (KR)
YUHAN CORP (KR)
YUHAN CORP (KR)
International Classes:
C07K16/28; A61K39/00; A61P35/00; A61P37/04; C07K16/32
Domestic Patent References:
| WO2019016402A1 | 2019-01-24 | |||
| WO2016149665A1 | 2016-09-22 | |||
| WO2018085731A2 | 2018-05-11 | |||
| WO2017173321A1 | 2017-10-05 |
Foreign References:
| US20160152722A1 | 2016-06-02 |
Other References:
See also references of EP 4004054A4
Attorney, Agent or Firm:
YOU ME PATENT AND LAW FIRM (KR)
Download PDF: